MedPath

TARINA 24 FE

These highlights do not include all the information needed to use TARINA  24 Fe safely and effectively. See Full Prescribing Information for TARINA 24 Fe. Tarina 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) for Oral Use Initial U.S. Approval: 1968

Approved
Approval ID

557fa655-c40f-4ecb-bd18-4820c7e15e4b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2023

Manufacturers
FDA

Afaxys Pharma, LLC

DUNS: 080508656

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50102-224
Application NumberANDA207504
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate
Product Specifications
Effective DateNovember 2, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TARINA 24 FE - FDA Drug Approval Details